{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:21:15Z","timestamp":1793330475649,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study was a randomized controlled trial to evaluate efficacy and safety of the usage of intravenous tranexamic acid during posterior operation of multilevel thoracic spine stenosis for controlling perioperative blood loss.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixty eight patients with multilevel thoracic spine stenosis were randomized into the tranexamic acid group receiving 15\u00a0mg\/kg body weight before the skin incision was made and 1\u00a0mg\/kg body weight per hour during operation or the control group receiving the same dose of placebo (0.9% sodium chloride solution) intravenously. Pedicle screw fixation, laminectomy and selective discectomy were performed. Intraoperative and perioperative total blood loss were compared. The necessity and amount for blood transfusion, blood coagulation function, durations of postoperative hospital stays were compared. The complications of tranexamic acid were also investigated such as cardiovascular and cerebrovascular events, lower limb venous thrombosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were no statistically significant differences in age, gender, body mass index, ASA status, pathology required surgery, preoperative hemoglobin, operation time, laminectomy segments and discectomy segments between the tranexamic acid and control groups. The intraoperative blood loss (455.9\u2009\u00b1\u2009206.6\u00a0ml vs 580.6\u2009\u00b1\u2009224.3\u00a0ml, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and total blood loss (675.3\u2009\u00b1\u2009170.3\u00a0ml vs 936.8\u2009\u00b1\u2009306.4\u00a0ml, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) in tranexamic acid group were significant lower than those in control group. The means of blood unit transfused (2.5\u2009\u00b1\u20091.0 vs 4.7\u2009\u00b1\u20092.4, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and Hb reduction in 48\u00a0h (22.5\u2009\u00b1\u20093.4\u00a0g\/L vs 25.3\u2009\u00b1\u20093.9\u00a0g\/L, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) were significantly lower in tranexamic acid group than that in control group. There were no statistically significant differences in blood coagulation function pre-operation or 48\u00a0h post-operation between the tranexamic acid and the control groups. The requirements for patients to receive blood transfusion were fewer and durations of post-operational hospital stays were shorter in the tranexamic acid group, however, the difference did not achieve statistical significance. There was no significant difference in superficial or deep venous thrombosis of lower limbs or deterioration of neurological function between tranexamic acid group and control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Application of intravenous tranexamic acid significantly reduces intraoperative and perioperative total blood loss without significant side effects in posterior operation of multilevel thoracic spine stenosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>At Chinese Clinal Trial Registry. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/\">http:\/\/www.chictr.org.cn\/<\/jats:ext-link>, ChiCTR2100054221. Registered on 11\/12\/2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-022-05361-2","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T19:02:43Z","timestamp":1651518163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The efficacy and safety of intravenous tranexamic acid in patients with posterior operation of multilevel thoracic spine stenosis: a prospective randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Tan","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Bingtao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Zhaoqing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhongqiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"5361_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ocl.2015.08.014","volume":"47","author":"JD Jennings","year":"2016","unstructured":"Jennings JD, Solarz MK, Haydel C. Application of Tranexamic Acid in Trauma and Orthopedic Surgery. Orthop Clin North Am. 2016;47:137\u201343.","journal-title":"Orthop Clin North Am"},{"key":"5361_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2019.05.029","volume":"66","author":"RJ Perez-Roman","year":"2019","unstructured":"Perez-Roman RJ, Lugo-Pico JG, Burks JD, Madhavan K, Sheinberg D, Green BA, et al. Short-term safety of tranexamic acid use in posterior cervical decompression and fusion surgery. J Clin Neurosci. 2019;66:41\u20134.","journal-title":"J Clin Neurosci"},{"key":"5361_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/BSD.0000000000000808","volume":"32","author":"C Slattery","year":"2019","unstructured":"Slattery C, Kark J, Wagner T, Verma K. The Use of Tranexamic Acid to Reduce Surgical Blood Loss: A Review Basic Science, Subspecialty Studies, and The Evolution of Use in Spine Deformity Surgery. Clin Spine Surg. 2019;32:46\u201350.","journal-title":"Clin Spine Surg"},{"issue":"Suppl 1","key":"5361_CR4","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1007\/s00586-004-0716-2","volume":"13","author":"DT Neilipovitz","year":"2004","unstructured":"Neilipovitz DT. Tranexamic acid for major spinal surgery. Eur Spine J. 2004;13(Suppl 1):S62\u20135.","journal-title":"Eur Spine J"},{"key":"5361_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00586-016-4792-x","volume":"26","author":"G Li","year":"2017","unstructured":"Li G, Sun TW, Luo G, Zhang C. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis. Eur Spine J. 2017;26:140\u201354.","journal-title":"Eur Spine J"},{"key":"5361_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000542-198303000-00016","volume":"58","author":"JB Gross","year":"1983","unstructured":"Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58:277\u201380.","journal-title":"Anesthesiology"},{"key":"5361_CR7","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224\u201330.","journal-title":"Surgery"},{"key":"5361_CR8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jspd.2019.04.005","volume":"7","author":"P Bosch","year":"2019","unstructured":"Bosch P, Kenkre TS, Soliman D, Londino JA, Novak NE. Comparison of the Coagulation Profile of Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion With and Without Tranexamic Acid. Spine Deform. 2019;7:910\u20136.","journal-title":"Spine Deform"},{"key":"5361_CR9","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1097\/TA.0b013e318292cc54","volume":"74","author":"LM Napolitano","year":"2013","unstructured":"Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J TraumaAcute Care Surg. 2013;74:1575\u201386.","journal-title":"J TraumaAcute Care Surg"},{"key":"5361_CR10","doi-asserted-by":"crossref","unstructured":"Fisher CG, Vaccaro AR, Patel AA, Whang PG, Thomas KC, Chi J, et al. Evidence-Based Recommendations for Spine Surgery. Spine (Phila Pa 1976). 2020;45:851\u20139.","DOI":"10.1097\/BRS.0000000000003512"},{"key":"5361_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00586-016-4899-0","volume":"26","author":"QM Yuan","year":"2017","unstructured":"Yuan QM, Zhao ZH, Xu BS. Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. Eur Spine J. 2017;26:131\u20139.","journal-title":"Eur Spine J"},{"key":"5361_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.wneu.2019.02.170","volume":"127","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu H, He F, Chen A, Yang H, Pi B. Does Tranexamic Acid Improve Bleeding, Transfusion, and Hemoglobin Level in Patients Undergoing Multilevel Spine Surgery? A Systematic Review and Meta-Analysis. World Neurosurg. 2019;127:289\u2013301.","journal-title":"World Neurosurg"},{"key":"5361_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.seminhematol.2003.11.025","volume":"41","author":"JD Tobias","year":"2004","unstructured":"Tobias JD. Strategies for minimizing blood loss in orthopedic surgery. Semin Hematol. 2004;41:145\u20136.","journal-title":"Semin Hematol"},{"key":"5361_CR14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1213\/ANE.0000000000001485","volume":"123","author":"D Willner","year":"2016","unstructured":"Willner D, Spennati V, Stohl S, Tosti G, Aloisio S, Bilotta F. Spine Surgery and Blood Loss: Systematic Review of Clinical Evidence. Anesth Analg. 2016;123:1307\u201315.","journal-title":"Anesth Analg"},{"key":"5361_CR15","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00586-013-2836-z","volume":"22","author":"Q Wang","year":"2013","unstructured":"Wang Q, Liu J, Fan R, Chen Y, Yu H, Bi Y, et al. Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial. Eur Spine J. 2013;22:2035\u20138.","journal-title":"Eur Spine J"},{"key":"5361_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3340\/jkns.2016.0505.004","volume":"60","author":"HY Choi","year":"2017","unstructured":"Choi HY, Hyun SJ, Kim KJ, Jahng TA, Kim HJ. Effectiveness and Safety of Tranexamic Acid in Spinal Deformity Surgery. J Korean Neurosurg Soc. 2017;60:75\u201381.","journal-title":"J Korean Neurosurg Soc"},{"key":"5361_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12891-019-2762-2","volume":"20","author":"J Bai","year":"2019","unstructured":"Bai J, Zhang P, Liang Y, Wang J, Wang Y. Efficacy and safety of tranexamic acid usage in patients undergoing posterior lumbar fusion: a meta-analysis. BMC Musculoskelet Disord. 2019;20:390.","journal-title":"BMC Musculoskelet Disord"},{"key":"5361_CR18","doi-asserted-by":"crossref","unstructured":"Peters A, Verma K, Slobodyanyuk K, et al. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial. Spine (Phila Pa 1976) 2015;40:E443\u20139.","DOI":"10.1097\/BRS.0000000000000799"},{"key":"5361_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/bja\/aew434","volume":"118","author":"MJ Colomina","year":"2017","unstructured":"Colomina MJ, Koo M, Basora M, Cheriyan T, Hoelscher C, Schwab F, et al. Intraoperative tranexamic acid use in major spine surgery in adults: a multicentre, randomized, placebo-controlled trial. Br J Anaesth. 2017;118:380\u201390.","journal-title":"Br J Anaesth"},{"key":"5361_CR20","doi-asserted-by":"crossref","unstructured":"Bednar DA, Bednar VA, Chaudhary A, Farrokhyar F. Tranexamic acid for hemostasis in the surgical treatment of metastatic tumors of the spine. Spine (Phila Pa 1976). 2006;31:954\u20137.","DOI":"10.1097\/01.brs.0000209304.76581.c5"},{"key":"5361_CR21","doi-asserted-by":"publisher","first-page":"e572","DOI":"10.1016\/j.wneu.2017.11.070","volume":"110","author":"LM Carabini","year":"2018","unstructured":"Carabini LM, Moreland NC, Vealey RJ, Bebawy JF, Koski TR, Koht A, et al. A Randomized Controlled Trial of Low-Dose Tranexamic Acid versus Placebo to Reduce Red Blood Cell Transfusion During Complex Multilevel Spine Fusion Surgery. World Neurosurg. 2018;110:e572\u20139.","journal-title":"World Neurosurg"},{"key":"5361_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013643","volume":"97","author":"P Xue","year":"2018","unstructured":"Xue P, Yang J, Xu X, Liu T, Huang Y, Qiao F, et al. The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study. Medicine (Baltimore). 2018;97: e13643.","journal-title":"Medicine (Baltimore)"},{"key":"5361_CR23","doi-asserted-by":"crossref","unstructured":"Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine (Phila Pa 1976). 2008;33:2577\u201380.","DOI":"10.1097\/BRS.0b013e318188b9c5"},{"key":"5361_CR24","doi-asserted-by":"crossref","unstructured":"Xu D, Chen X, Li Z, Ren Z, Zhuang Q, Li S. Tranexamic acid reduce hidden blood loss in posterior lumbar interbody fusion (PLIF) surgery. Medicine. 2020;99:11(e19552).","DOI":"10.1097\/MD.0000000000019552"},{"key":"5361_CR25","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s00586-013-2774-9","volume":"22","author":"ZJ Li","year":"2013","unstructured":"Li ZJ, Fu X, Xing D, Zhang HF, Zang JC, Ma XL. Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials. Eur Spine J. 2013;22:1950\u20137.","journal-title":"Eur Spine J"},{"key":"5361_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3171\/2020.1.SPINE191464","volume":"33","author":"J Ehresman","year":"2020","unstructured":"Ehresman J, Pennington Z, Schilling A, Medikonda R, Huq S, Merkel KR, et al. Cost- benefit analysis of tranexamic acid and blood transfusion in elective lumbar spine surgery for degenerative pathologies. J Neurosurg Spine. 2020;33:177\u201385.","journal-title":"J Neurosurg Spine"},{"key":"5361_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/CM9.0000000000000108","volume":"132","author":"L Yuan","year":"2019","unstructured":"Yuan L, Zeng Y, Chen ZQ, Zhang XL, Mai S, Song P, et al. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis. Chin Med J (Engl). 2019;132:577\u201388.","journal-title":"Chin Med J (Engl)"},{"key":"5361_CR28","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1097\/BSD.0000000000000851","volume":"32","author":"N Wanderman","year":"2019","unstructured":"Wanderman N, Robinson W, Carlson B, Bydon M, Currier B, Huddleston P, et al. Tranexamic Acid in Thoracic and Lumbar Fusions and Perioperative Blood Loss. Clin Spine Surg. 2019;32:E462\u20138.","journal-title":"Clin Spine Surg"},{"key":"5361_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3928\/01477447-20160301-05","volume":"39","author":"ZX Lin","year":"2016","unstructured":"Lin ZX, Woolf SK. Safety, Efficacy, and Cost-effectiveness of Tranexamic Acid in Orthopedic Surgery. Orthopedics. 2016;39:119\u201330.","journal-title":"Orthopedics"},{"key":"5361_CR30","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1097\/BSD.0000000000000860","volume":"33","author":"BS Ko","year":"2020","unstructured":"Ko BS, Cho KJ, Kim YT, Park JW, Kim NC. Does Tranexamic Acid Increase the Incidence of Thromboembolism After Spinal Fusion Surgery? Clin Spine Surg. 2020;33:E71\u20135.","journal-title":"Clin Spine Surg"},{"key":"5361_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.spinee.2015.01.013","volume":"15","author":"T Cheriyan","year":"2015","unstructured":"Cheriyan T, Maier SP 2nd, Bianco K, Slobodyanyuk K, Rattenni RN, Lafage V, et al. Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J. 2015;15:752\u201361.","journal-title":"Spine J"},{"key":"5361_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jspd.2017.08.007","volume":"6","author":"JD Lin","year":"2018","unstructured":"Lin JD, Lenke LG, Shillingford JN, Laratta JL, Tan LA, Fischer CR, et al. Safety of a High-Dose Tranexamic Acid Protocol in Complex Adult Spinal Deformity: Analysis of 100 Consecutive Cases. Spine Deform. 2018;6:189\u201394.","journal-title":"Spine Deform"},{"key":"5361_CR33","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00586-017-5230-4","volume":"26","author":"KT Kim","year":"2017","unstructured":"Kim KT, Kim CK, Kim YC, Juh HS, Kim HJ, Kim HS, et al. The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study. Eur Spine J. 2017;26:2851\u20137.","journal-title":"Eur Spine J"},{"key":"5361_CR34","first-page":"1","volume":"24","author":"MN Pernik","year":"2020","unstructured":"Pernik MN, Dosselman LJ, Aoun SG, Walker AD, Hall K, Peinado Reyes V, et al. The effectiveness of tranexamic acid on operative and perioperative blood loss in long-segment spinal fusions: a consecutive series of 119 primary procedures. J Neurosurg Spine. 2020;24:1\u20137.","journal-title":"J Neurosurg Spine"},{"key":"5361_CR35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2106\/JBJS.L.01602","volume":"96","author":"V Goz","year":"2014","unstructured":"Goz V, McCarthy I, Weinreb JH, Dallas K, Bendo JA, Lafage V, et al. Venous thromboembolic events after spinal fusion: which patients are at high risk? J Bone Joint Surg. 2014;96:936\u201342.","journal-title":"J Bone Joint Surg"},{"key":"5361_CR36","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.21037\/atm.2019.05.36","volume":"7","author":"JS Yoo","year":"2019","unstructured":"Yoo JS, Ahn J, Karmarkar SS, Lamoutte EH, Singh K. The use of tranexamic acid in spine surgery. Ann Transl Med. 2019;7:S172.","journal-title":"Ann Transl Med"},{"key":"5361_CR37","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1016\/j.wneu.2019.01.040","volume":"125","author":"H Sun","year":"2019","unstructured":"Sun H, Deng L, Deng J, Wang J, Zhang H, Chen K, et al. The Efficacy and Safety of Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Patients Treated with Posterior Lumbar Interbody Fusion. World Neurosurg. 2019;125:e198-204.","journal-title":"World Neurosurg"},{"key":"5361_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/2192568219888446","volume":"11","author":"V Arun-Kumar","year":"2021","unstructured":"Arun-Kumar V, Naresh-Babu J. Is There a Role for Preoperative Local Infiltration of Tranexamic Acid in Elective Spine Surgery? A Prospective Randomized Controlled Trial Analyzing the Efficacy of Intravenous, Local Infiltration, and Topical Administration of Tranexamic Acid. Global Spine J. 2021;11:21\u20137.","journal-title":"Global Spine J"},{"key":"5361_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13063-019-3231-9","volume":"20","author":"S Hui","year":"2019","unstructured":"Hui S, Tao L, Mahmood F, Xu D, Ren Z, Chen X, et al. Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS): study protocol for a prospective, randomized, double-blind, non-inferiority trial. Trials. 2019;20:125.","journal-title":"Trials"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05361-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-022-05361-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05361-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T19:08:16Z","timestamp":1651518496000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-022-05361-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5361"],"URL":"https:\/\/doi.org\/10.1186\/s12891-022-05361-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of Peking University International Hospital. Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Tan Lei, Wen Bingtao, Guo Zhaoqing, Chen Zhongqiang, Liu Xin declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}